A new study found that Ozempic's main ingredient may treat people with type 1 diabetes, control blood sugar, and lose weight.

A clinical trial for semaglutide, the active ingredient in Ozempic, found that it improved blood sugar control in people with ...

In a small cell therapy trial, 10 out of 12 people with type 1 diabetes no longer needed supplemental insulin, even a year after treatment.

Children with diabetes who inhaled their mealtime doses of insulin did just as well as those who injected insulin under the ...

Medtronic, Beta Bionics and Tandem Diabetes Care showcased planned patch pumps at the conference, while Senseonics shared ...

The endocrinologist and researcher was one of several investigators who presented Phase 3 clinical trial results at the 85th Scientific Sessions of the American Diabetes Association for a long-lasting ...

The chief product and customer experience officer said Insulet has seen an uptick in users with Type 2 diabetes since ...

In a trial, the daily GLP-1 pill showed "significant" results and similar side effects to injectable GLP-1 drugs like Ozempic ...

Recent restructuring efforts at the Food and Drug Administration may have been well-intentioned, but they risk undermining the very innovation and domestic capacity the president seeks to promote.

A person uses Afrezza inhaled insulin powder. [Image courtesy of MannKind] New study results demonstrated the safety and efficacy of the MannKind Afrezza inhaled insulin offering for children with ...

Vertex, like other drug companies, declined to announce the treatment’s cost before the Food and Drug Administration approves it. A Vertex spokeswoman said the company had data only on the ...